Sunstone Life Science Ventures is a prominent Danish / Nordic life-sciences venture capital investment firm based in Copenhagen, Denmark, investing in early-stage life-sciences companies developing novel therapeutics aEUR" representing one of Europe's established dedicated life-sciences / biotech VC firms. The firm was founded in 2007 (following its origin as Sunstone Capital, which covered both tech and life-sciences) and subsequently spun out Sunstone Life Science Ventures as a dedicated life-sciences vehicle. The firm has raised multiple institutional funds (Sunstone Life Science Ventures Fund I, II, III, IV) with aggregate AUM exceeding EUR 400-500 million+ across vintages, typically writing initial check sizes in the EUR 2 to 10 million range at Series A and follow-on stages. The firm operates alongside other leading Nordic life-sciences VCs such as Novo Holdings (the investment arm of the Novo Nordisk Foundation), HealthCap, and Via Venturi. Notable portfolio companies have included various European biotech companies producing multiple IPO exits and trade sales.